In its 10 th year of publication Human Vaccines & Immunotherapeutics (HV&I) has become well-established in the vaccine community as an important forum for companies, academics, governmental and non-governmental organizations in this field. Our journal contains a mix of high-quality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. Its unique and exclusive focus on vaccines and immunotherapeutics for human use coupled with the rapid and efficient editorial processing of submitted papers has allowed HV&I to continuously increase its content and progressively improve its standing relative to other journals in the field.
Obviously, the successful development of HV&I would not have been possible without the many scientists and editors who have served as peer reviewers for HV&I. We want to take this opportunity to thank all our reviewers for their time and commitment. All peer reviewers of 2013 are listed below.
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